Stay updated on the latest breakthroughs in biotechnology. From advancements in gene editing technologies like CRISPR to developments in cell and gene therapies, explore how biotech is driving medical innovation and transforming patient care.
Explore the latest biotech innovations from October 6-13, 2025: AstraZeneca’s oncology trials, FDA approvals for IPF and CSCC, allogeneic CAR-NK cells, and trends in direct-to-consumer
Genmab acquires Merus for $8B, FDA approves Alzheimer’s blood test, and Trump Administration secures drug pricing deals. Complete biotech industry analysis. 1. Genmab’s $8 Billion
The final week of September brought seismic shifts across the pharmaceutical and biotechnology sectors, with an $8 billion oncology acquisition, leadership changes at Big Pharma
After more than half a year without a sizable biotech IPO, LB Pharmaceuticals just raised $285 million in an upsized Nasdaq offering. For an industry
After months of biotech companies avoiding public markets like the plague, LB Pharmaceuticals just broke the drought with a $285 million initial public offering that
August 2025 will be remembered as a watershed moment for the biotechnology industry, with over 20 companies announcing significant layoffs as the sector undergoes its
Sector evolution marked by breakthrough approvals, billion-dollar transactions, and emerging health challenges Recent global biotech developments showcase the sector’s dynamic nature, with breakthrough drug approvals,
Sector-wide fundraising activity reflects continued capital needs across biotech industry August 12 marked a particularly active day for biotech fundraising, with companies including 180 Life
Indian pharmaceutical company achieves peak performance amid ongoing financial pressures Windlas Biotech reported record Q2 net sales of approximately ₹210 crore (~$25 million USD) and
Pfizer and BioNTech have reached a substantial $740 million settlement agreement with CureVac to resolve a complex patent dispute involving foundational mRNA technology that underpins
